Search research articles
Contact Us
Filters
Showing results (561-570 of 579) with videos related to
Page
of 58
Sort By:
Ophthalmology
|
October 3, 2013
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies
Ursula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, et al.
American Journal of Ophthalmology
|
May 25, 2020
Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity
Jacque L Duncan, Wendi Liang, Maureen G Maguire, et al.
JAMA Ophthalmology
|
November 19, 2020
Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report From a US Food and Drug Administration-Cosponsored Forum
Frank Brodie, Michael Repka, Stephen Allan Burns, et al.
Ophthalmology. Retina
|
March 26, 2021
OCT Signs of Early Atrophy in Age-Related Macular Degeneration: Interreader Agreement: Classification of Atrophy Meetings Report 6
Zhichao Wu, Maximilian Pfau, Barbara A Blodi, et al.
Ophthalmology Science
|
March 9, 2026
Geographic Atrophy on Fundus Autofluorescence and Color Fundus Photographs: Association with Deep Visual Sensitivity Losses
Erin E Gee, Robyn H Guymer, Barbara A Blodi, et al.
Ophthalmology
|
July 23, 2015
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, et al.
Translational Vision Science & Technology
|
October 9, 2024
Endpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study
Maureen G Maguire, David G Birch, Jacque L Duncan, et al.
American Journal of Ophthalmology
|
August 25, 2022
Baseline Microperimetry and OCT in the RUSH2A Study: Structure-Function Association and Correlation With Disease Severity
Eleonora M Lad, Jacque L Duncan, Wendi Liang, et al.
Ophthalmology
|
February 13, 2018
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III
Eric B Suhler, Alfredo Adán, Antoine P Brézin, et al.
American Journal of Medicine Open
|
April 1, 2025
Returning Individual-Level Urgent or Emergent Research Results to Participants: The Project Baseline Health Study Experience
Neha Pagidipati, Brooke Heidenfelder, Lydia Coulter Kwee, et al.
Page
of 58
Search research articles
Search
Showing results (561-570 of 579) with videos related to
Sort By:
Page
of 58
Ophthalmology
|
October 3, 2013
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies
Ursula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, et al.
American Journal of Ophthalmology
|
May 25, 2020
Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity
Jacque L Duncan, Wendi Liang, Maureen G Maguire, et al.
JAMA Ophthalmology
|
November 19, 2020
Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging: Report From a US Food and Drug Administration-Cosponsored Forum
Frank Brodie, Michael Repka, Stephen Allan Burns, et al.
Ophthalmology. Retina
|
March 26, 2021
OCT Signs of Early Atrophy in Age-Related Macular Degeneration: Interreader Agreement: Classification of Atrophy Meetings Report 6
Zhichao Wu, Maximilian Pfau, Barbara A Blodi, et al.
Ophthalmology Science
|
March 9, 2026
Geographic Atrophy on Fundus Autofluorescence and Color Fundus Photographs: Association with Deep Visual Sensitivity Losses
Erin E Gee, Robyn H Guymer, Barbara A Blodi, et al.
Ophthalmology
|
July 23, 2015
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, et al.
Translational Vision Science & Technology
|
October 9, 2024
Endpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study
Maureen G Maguire, David G Birch, Jacque L Duncan, et al.
American Journal of Ophthalmology
|
August 25, 2022
Baseline Microperimetry and OCT in the RUSH2A Study: Structure-Function Association and Correlation With Disease Severity
Eleonora M Lad, Jacque L Duncan, Wendi Liang, et al.
Ophthalmology
|
February 13, 2018
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III
Eric B Suhler, Alfredo Adán, Antoine P Brézin, et al.
American Journal of Medicine Open
|
April 1, 2025
Returning Individual-Level Urgent or Emergent Research Results to Participants: The Project Baseline Health Study Experience
Neha Pagidipati, Brooke Heidenfelder, Lydia Coulter Kwee, et al.
Page
of 58